Head-to-head comparison of cerebral blood flow single-photon emission computed tomography and 18 F-fluoro-2-deoxyglucose positron emission tomography in the diagnosis of Alzheimer disease.
David P NadebaumNatasha KrishnadasAurora M T PoonVictor KalffMeir LichtensteinVictor L VillemagneGareth JonesChristopher C RowePublished in: Internal medicine journal (2021)
18 F-FDG PET is superior to CBF-SPECT in detecting AD among patients referred for the assessment of cognitive impairment.